Ardelyx (NASDAQ:ARDX) Rating Reiterated by Piper Sandler
Piper Sandler reaffirmed their overweight rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a report released on Friday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the biopharmaceutical company’s stock. A number of other research analysts also recently weighed in on ARDX. Citigroup increased their price target on Ardelyx […]
More Stories
Nobility Homes (OTCMKTS:NOBH) Posts Quarterly Earnings Results
Nobility Homes (OTCMKTS:NOBH – Get Free Report) released its quarterly earnings data on Thursday. The construction company reported $0.63 earnings...
Nobility Homes (OTCMKTS:NOBH) Posts Quarterly Earnings Results
Nobility Homes (OTCMKTS:NOBH – Get Free Report) released its quarterly earnings data on Thursday. The construction company reported $0.63 earnings...
Nexo Price Down 5.5% Over Last 7 Days (NEXO)
Nexo (NEXO) traded 1.5% higher against the US dollar during the 24 hour period ending at 12:00 PM ET on...
Nexo Price Down 5.5% Over Last 7 Days (NEXO)
Nexo (NEXO) traded 1.5% higher against the US dollar during the 24 hour period ending at 12:00 PM ET on...
BORA Price Tops $0.15 (BORA)
BORA (BORA) traded 10.8% higher against the US dollar during the 1-day period ending at 12:00 PM E.T. on January...
BORA Price Tops $0.15 (BORA)
BORA (BORA) traded 10.8% higher against the US dollar during the 1-day period ending at 12:00 PM E.T. on January...